Depression
<乌鸦传媒 class="page-description">More in Depression
Lumateperone is already FDA approved for schizophrenia and bipolar disorder
No approved agent has the same mechanism of action as seltorexant
News and commentary from the psychiatry world
Health news and commentary gathered by 乌鸦传媒 staff
News and commentary from the psychiatry world
Health news and commentary gathered by 乌鸦传媒 staff
News and commentary from the psychiatry world
The loss of William West Jr. forces us to consider the role of health systems in staff well-being
GLP-1 treatment was tied to lower risks of suicidal ideation, attempts vs lifestyle interventions
Nearly one in four men over 75 live alone, leaving them vulnerable to depression and suicide
News and commentary from the psychiatry world
Secondary analysis suggests lack of clinically meaningful differences in effectiveness
The District of Columbia called the algorithm "dopamine-inducing"
